There’s this strategy in business called the decoy effect, where marketers price things differently to manipulate customers.

Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

Takeaway: Pharmaceutical companies are facing multiple lawsuits across the country over similar claims of monopolistic tactics designed to drive up the costs of life-saving medications.

Rady Children's Hospital reported a 500% surge in behavioral health ER visits over the last decade and suicide remains the ...

Fees matter to investor returns. A widespread reduction of them could be coming. Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 ...

Members of the family who own OxyContin maker Purdue Pharma ... access through lawsuits. Connecticut Attorney General William Tong, a Democrat, said the settlement will be a big hit to the ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to US$7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...

Warren pointed out that the government financial disclosures Kennedy filed as part of the confirmation process said he had made $2.5 million from a law firm that has sued vaccine manufacturers.